Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Partial adenosine deaminase deficiency: another family from southern Africa.

Hart SL, Lane AB, Jenkins T.

Hum Genet. 1986 Nov;74(3):307-12.

PMID:
3781559
2.

Normal and mutant human adenosine deaminase genes.

Akeson AL, Wiginton DA, Hutton JJ.

J Cell Biochem. 1989 Mar;39(3):217-28. Review.

PMID:
2651461
3.

Analysis of normal and mutant forms of human adenosine deaminase - a review.

Daddona PE, Kelley WN.

Mol Cell Biochem. 1980 Feb 8;29(2):91-101. Review.

4.

Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.

Zegers BJ, Stoop JW.

Clin Biochem. 1983 Feb;16(1):43-7. Review.

PMID:
6407780
5.

Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.

Hershfield MS.

Semin Hematol. 1998 Oct;35(4):291-8. Review.

PMID:
9801258
7.

Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.

Hirschhorn R.

Birth Defects Orig Artic Ser. 1983;19(3):73-81. Review. No abstract available.

PMID:
6418227
8.

Genotype is an important determinant of phenotype in adenosine deaminase deficiency.

Hershfield MS.

Curr Opin Immunol. 2003 Oct;15(5):571-7. Review.

PMID:
14499267
9.

Recent progress in the molecular genetic analysis of erythroenzymopathy.

Fujii H, Miwa S.

Am J Hematol. 1990 Aug;34(4):301-10. Review.

PMID:
2164322
10.

[Adenosine deaminase activity and immune dysfunction (author's transl)].

Bremer H, Bauer I, Brock J.

Allerg Immunol (Leipz). 1981;27(1):3-13. Review. German.

PMID:
6455054
11.

Molecular genetics and potential gene therapy.

Orkin SH.

Clin Immunol Immunopathol. 1986 Jul;40(1):151-6. Review.

PMID:
3521968
12.

Somatic cell gene therapy: the model of adenosine deaminase deficiency.

Van Beusechem VW, Kukler A, Bakx TA, Valerio D.

Bone Marrow Transplant. 1989 Dec;4 Suppl 4:133-6. Review. No abstract available.

PMID:
2697426

Supplemental Content

Support Center